![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/05/15/2882391/0/en/PharmaTher-s-Sairiyo-Therapeutics-Submits-Clinical-Trial-Application-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html
https://www.globenewswire.com/news-release/2024/05/01/2873176/0/en/PharmaTher-s-Sairiyo-Therapeutics-Completes-Clinical-and-Regulatory-Package-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html